Shawn Gahr is a Co-founder and Board Member of Novoron Bioscience, where he has played a key role in securing funding through multiple rounds. With over a decade of experience in financial planning and analysis, Shawn has worked with Fortune 500 companies across industries like healthcare, financial services, IT, government, and automotive. He has also contributed to business development, project management, and strategic efforts for successful startups. Shawn holds a BS in Economics from Willamette University and a Master’s degree in International Economics from University of California, San Diego (UCSD), bringing a diverse background to his work in biotechnology and finance.